PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: ChromaDex, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Life Extension® Launches New Product Containing ChromaDex’s pTeroPure® pTerostilbene - Life Extension, launched a product featuring ChromaDex’s (CDXC.OB) pTeroPure pterostilbene, which is now available in many local health food stores and natural retailers
Life Extension® Launches New Product Containing ChromaDex’s pTeroPure® pTerostilbene

 

NewswireToday - /newswire/ - Irvine, CA, United States, 2011/04/06 - Life Extension, launched a product featuring ChromaDex’s (CDXC.OB) pTeroPure pterostilbene, which is now available in many local health food stores and natural retailers.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Life Extension, a global authority on nutrition, health, and wellness and a provider of dietary supplements, has launched a product featuring ChromaDex’s (CDXC.OB) pTeroPure pterostilbene, which is now available in many local health food stores and natural retailers.

Life Extension pTeroPure contains 50 mg of pTeroPure pterostilbene, a compound naturally found in blueberries. Pterostilbene has been shown to be superior to a similar compound, resveratrol, which occurs naturally in grapes and is commonly associated with the heart-healthy benefits of red wine. Pterostilbene has a higher potential for cellular uptake due to its better absorption and longer half-life in the blood, properties that may provide enhanced physiological benefits.

ChromaDex’s pTeroPure pterostilbene is a 99%-plus pure pterostilbene that is superior to other stilbenes on the market due to its sustainable sourcing and ultra-high purity. ChromaDex was recently presented with the Most Promising Ingredient of the Year award for pTeroPure by Frost & Sullivan, an independent research company.
“pTeroPure continues to make waves in the natural products industry and is an ingredient in more than 17 dietary supplements,” remarks Jeremy Bartos, PhD, ChromaDex’s pTeroPure Product Manager. “This partnership with Life Extension adds to that growing list and is indicative of the rising demand for this promising ingredient across the industry. We look forward to utilizing Life Extension’s market expertise, reputation, and retail influence to increase the presence of pTeroPure in the consumer market.”

This product is now available through domestic health and natural food stores and online at lef.org/.

About Life Extension
Life Extension is a global nonprofit research foundation and an authority on nutrition, health and wellness. It provides scientific information on anti-aging and optimal health and produces nutraceuticals for the dietary supplements industry.

About ChromaDex

ChromaDex (chromadex.com) is an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries. The company has an impressive pipeline of new ingredients, including its pTeroPure pterostilbene on which it has worldwide, exclusive patent rights. ChromaDex is a publicly-traded life-sciences company (OTC stock symbol CDXC.OB).

ChromaDex Forward-Looking Statements
Any statements that are not historical facts contained in this release are forward-looking statements. Actual results may differ materially from those projected or implied in any forward-looking statements. Such statements involve risks and uncertainties, including but not limited to those relating to product and customer demand, market acceptance of our products, the effect of economic conditions both nationally and internationally, ability to protect our intellectual property rights, impact of any litigation or infringement actions brought against us, competition from other providers and products, risks in product development, our ability to raise capital to fund continuing operations, the ability to complete transactions, and other factors discussed from time to time in the Company’s Securities and Exchange Commission filings. The Company undertakes no obligation to update or revise any forward-looking statement for events or circumstances after the date on which such statement is made except as required by law.

Life Extension Contact
Rey Searles, Director of Marketing
P: 954-766-8433 / E: rsearles[.]lef.org.

ChromaDex Investor Inquiries:
Liviakis Financial Communications, Inc.
John M. Liviakis, President
P: 415-389-4670 / E: John[.]Liviakis.com.

Media Inquiries:
Carolyn Hawley, Canale Communications
P: 619-849-5375 / E: carolyn[.]canalecomm.com.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: ChromaDex, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Life Extension® Launches New Product Containing ChromaDex’s pTeroPure® pTerostilbene

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Laura Carney - ChromaDex.com 
949-419-0288 LauraC[.]chromadex.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any ChromaDex, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From ChromaDex, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y Dosimetry Software in Europe
FDA Grants Priority Review to Genentech’s Lucentis® (Ranibizumab Injection) Supplemental Biologics License Application
Genentech’s TECENTRIQ® (Atezolizumab) Shows Significant Survival Advantage Compared to Chemotherapy

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  Triggr & Bloom





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)